PDA

View Full Version : jnj

Pages : [1] 2 3 4 5 6
  1. Xerox, GE, Cabot, J&J, Ticketmaster are big movers
  2. Healthcare Isn´t Always Defense
  3. Johnson & Johnson closing Israeli headquarters
  4. Practice Greenhealth, J&J Team Up for Sustainability Training Program
  5. Stocks on the move: AutoNation, Expedia, General Electric, J&J
  6. Drug stocks gain as broader market stalls
  7. China quality watchdog says J&J baby products are safe
  8. Health Highlights: March 23, 2009
  9. Johnson & Johnson closes Israel HQ
  10. Johnson and Johnson (JNJ) PriceWatch Alert With 8.32% Downside Protection
  11. Zacks Analyst Blog Highlights: Sanofi-Aventis, Johnson & Johnson, AIG, Palm, Inc., an
  12. Documents Show that Psychiatrist Promised Favorable Results for Drug Company
  13. News > Unternehmensnachrichten > Promise of Nursing Gala to Raise Funds for ...
  14. Promise of Nursing Gala to Raise Funds for Nursing School Grants, Fellowships and Sch
  15. Promise of Nursing Gala to Raise Funds for Nursing School Grants, Fellowships and Sch
  16. Documents Show that Psychiatrist Promised Favorable Results for Drug Company
  17. CHINA: Authorities Give OK To J&J Products
  18. China concludes Johnson & Johnson products are safe for babies
  19. Johnson and Johnson (JNJ) PriceWatch Alert Down To $48.93 Break Even
  20. FDA Panel Recommends Approval of J&J’s Rivaroxaban
  21. J&J sponge cuts catheter infection risk-study
  22. China concludes Johnson & Johnson products are safe for babies
  23. Breaking campaign: J&J engages parents with Dry Skin Index
  24. J&J sponge cuts catheter infection risk-study
  25. Ranbaxy: gets Australia nod for antipsychotic drug
  26. Ranbaxy: gets Australia nod for antipsychotic drug
  27. USAID, HealthRight International and Johnson & Johnson partnership to Prevent HIV amo
  28. Former J&J worker gets jail time for invoice scam
  29. Wyeth: Now Approved to Kill More Bugs!
  30. Johnson and Johnson (JNJ) PriceWatch Alert for March 26, 2009
  31. MacroGenics Appoints New Vice President of Business Development
  32. China says Johnson & Johnson baby products OK
  33. J&J a Model of Stability
  34. Trust in J&J’s Dividend
  35. Trust in J&J’s Dividend
  36. Johnson & Johnson (JNJ): Bull of the Day for Mar 27, 2009
  37. Parents file lawsuit against J&J
  38. China says Johnson & Johnson baby products OK
  39. China says Johnson & Johnson baby products OK
  40. STOCKS NEWS EUROPE-Galapagos jumps on drug trials news
  41. Parents file lawsuit against J&J
  42. Teva gets FDA approval on version of J&J's Topamax
  43. J&J seeks benefits from Schering takeover
  44. DM Media Digest: J&J loves DRTV, HSBC's posh call handling, P&G's data diet
  45. J&J Connects With Celebs, Moms in Social Media
  46. Johnson And Johnson’s “Big Bubblin’ Stars” Campaign Promotes Toxic Baby Products?
  47. J&J Stent Bests Medtronic’s at Keeping Arteries Open
  48. MacroGenics names new vice president of business development
  49. J&J Connects With Celebs, Moms in Social Media
  50. Biederman's Finances: He Names His Own Price, and It's $550 an Hour
  51. Chinese Families to File Class Action Lawsuits Against Johnson and Johnson
  52. Israeli Biotechs Rally on M&A, State Aid; Bio Light Surges 332%
  53. Israeli Biotechs Rally on M&A, State Aid; Bio Light Surges 332%
  54. Johnson and Johnson (JNJ) PriceWatch Alert With 9.09% Downside Protection
  55. J&J wants a piece of Merck/Schering action
  56. BioForm Medical Strengthens Its Board of Directors With Three Aesthetics Industry Vet
  57. J&J Units Resolve Spat Over Razadyne-ER Patent
  58. Charges dropped against implant device companies
  59. Market Report -- In Play (JNJ)
  60. BioForm Medical Strengthens Its Board of Directors With Three Aesthetics Industry Vet
  61. Feds end kickback cases against implant makers
  62. J&J wants a piece of Merck/Schering action
  63. EANS-News: Epigenomics AG / Epigenomics AG Reports Financial Results for the Fiscal Y
  64. Ruling Adds Another Twist to Stent Case
  65. Watson Pharm Shrs Up; Wins Patent Suit Filed By JNJ Unit
  66. Japan Lab Strikes at Tuberculosis Scourge, May Beat J&J, Glaxo
  67. Ruling Adds Another Twist to Stent Case
  68. Johnson and Johnson (JNJ) PriceWatch Alert With 8.56% Downside Protection
  69. Another headache for Johnson & Johnson
  70. Some Doctors Looking to Cut Industry Funding
  71. J&J, Watson weigh options after ADHD patent ruling
  72. BRIEF: Nitto Denko to close Pleasant Prairie plant, cut 100 jobs
  73. Shire falls as J&J patent case raises generic concerns
  74. Johnson and Johnson (JNJ) PriceWatch Alert With 8.56% Downside Protection
  75. Toxic bubble bath: Johnson & Johnson responds
  76. Zacks Industry Outlook Highlights: Bristol-Myers, Johnson & Johnson and Abbott Labs
  77. Johnson and Johnson (JNJ) PriceWatch Alert At $48.27 Break Even
  78. J&J confounded by invalidated Concerta patent; Should FDA get stimulus bucks for IT?;
  79. Johnson and Johnson (JNJ) PriceWatch Alert Up To 15.15% Return
  80. SFDA: Johnson & Johnson Baby Bath Products are Safe
  81. New head-to-head clinical studies reveal Reach Ultraclean toothbrush and floss delive
  82. Beauty Blogger Partners with Johnson & Johnson
  83. Nuvera Biosciences signs license agreement with Veridex
  84. Johnson & Johnson personal care products safe to use - SFDA
  85. Johnson & Johnson personal care products safe to use - SFDA
  86. Johnson & Johnson personal care products safe to use - SFDA
  87. Johnson & Johnson personal care products safe to use - SFDA
  88. Johnson & Johnson personal care products safe to use - SFDA
  89. Johnson & Johnson personal care products safe to use - SFDA
  90. Johnson & Johnson personal care products safe to use - SFDA
  91. Johnson & Johnson personal care products safe to use - SFDA
  92. SFDA: Johnson & Johnson Baby Bath Products are Safe
  93. Johnson and Johnson (JNJ) PriceWatch Alert Bearish Price Movement
  94. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  95. Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results
  96. Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results
  97. Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results
  98. Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results
  99. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  100. Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results
  101. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  102. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  103. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  104. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  105. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  106. J&J: Co Doesn't Have Plans To Enter 'Biosimilars' Market
  107. Johnson and Johnson dental products 'improve plaque removal'
  108. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  109. Cohera Medical names new vice president of manufacturing
  110. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  111. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  112. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  113. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  114. WisBusiness: Pharma exec sees prevention, improved insurance access as keys to health
  115. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  116. Johnson and Johnson (JNJ) PriceWatch Alert for April 8, 2009
  117. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  118. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  119. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  120. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  121. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  122. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  123. Johnson & Johnson (JNJ) volatility Flat into EPS & Outlook
  124. Appeals Court Issues Ruling on Stent Patent Disputes
  125. RA Patients Choose Pain Over Poverty: Survey
  126. AUDREY'S SOCIETY WHIRL: Shared Interest Gala
  127. Johnson & Johnson - Financial and Strategic Analysis Review
  128. Johnson and Johnson (JNJ) PriceWatch Alert With Support Around $50.84
  129. Market Report -- In Play (JNJ)
  130. The Week Ahead
  131. Trade Deficit Keeps Improving
  132. Trade Deficit Keeps Improving
  133. Rutgers Business School wins national Johnson & Johnson competition beating nine othe
  134. J&J Cuts About 900 Positions From US Pharmaceuticals Unit
  135. Judge orders Boston Sci to pay royalties to J&J
  136. Judge orders Boston Sci to pay royalties to J&J
  137. Biotech Stock Mailbag: Medarex
  138. Johnson & Johnson to axe 900 jobs
  139. J&J backs longer marketing exclusivity for biotech drugs
  140. Johnson & Johnson Sales Reps Face Job Cuts As Top Drugs Go Generic
  141. Johnson & Johnson eliminating jobs
  142. RNCOS: Soaring Demand Driving Indian Baby Care Market
  143. EARNINGS OUTLOOK J&J expected to report lower earnings
  144. EARNINGS OUTLOOK J&J expected to report lower earnings
  145. EARNINGS OUTLOOK J&J expected to report lower earnings
  146. Johnson and Johnson (JNJ) PriceWatch Alert Bearish Price Movement
  147. EARNINGS OUTLOOK J&J expected to report lower earnings
  148. Markets to Open Lower on GM Bankruptcy Concerns and Critical Earnings Reports This We
  149. WallStSense.com Free Research Report for Shareholders of JNJ, BQI, NFX and CPN
  150. J&J earnings expected to fall; Mumbai retailers end Novartis boycott;
  151. J&J to cut 900 jobs, mostly in sales
  152. J&J to cut 900 jobs, mostly in sales
  153. Molecular Diagnostics Company, RedPath, Appoints Mark D. Myslinski as Chief Executive
  154. J&J, Schering-Plough get arthritis drug approval
  155. J&J, Schering-Plough get arthritis drug approval
  156. Stocks In Focus For Tuesday
  157. Wall St futures mixed after GS; eyes on Intel, J&J
  158. Wall St futures mixed after GS; eyes on Intel, J&J
  159. Johnson & Johnson Q1 earnings preview
  160. J&J eliminates 900 positions as Simponi is approved in Canada
  161. Johnson & Johnson Q1 earnings preview
  162. Stocks In Focus For Tuesday
  163. Wall St futures mixed after GS; eyes on Intel, J&J
  164. Wall St futures mixed after GS; eyes on Intel, J&J
  165. US STOCKS-Futures lower as Goldman issue eyed; J&J, data on tap
  166. Tuesday's Events: US Retail Sales, Fed Chairman Bernanke, Earnings
  167. Johnson & Johnson Reaffirms
  168. Johnson & Johnson 1Q Net Drops 2.5% On Falling Sales
  169. J&J Posts Lower Net but Backs Outlook
  170. Johnson and Johnson (JNJ) PriceWatch Alert Down To $42.85 Break Even
  171. Johnson & Johnson Reports 2009 First-Quarter Results:
  172. SmarTrend Morning Call - 4/14/2009
  173. US Stock Futures Little Changed After Retail Sales Data, J&J In Focus
  174. J&J reports moderately lower first-quarter earnings
  175. J&J Profit Slips on Drug Competition, Consumer Slump
  176. BEFORE THE BELL-Johnson & Johnson rises after earnings
  177. Economic data, Obama, Goldman Sachs, J&J, GM, Dendreon – Vialoux
  178. Strong dollar hits Johnson & Johnson
  179. US STOCKS SNAPSHOT-Wall St falls after retail sales, PPI data
  180. J&J profit tops forecast, shares jump
  181. Fastenal; Johnson & Johnson Net Falls
  182. J&J Beats on Light Revenues
  183. J&J Still Expects Slight Slowdown In Orthopedic Growth
  184. Strong dollar hits Johnson & Johnson
  185. J&J Still Expects Slight Slowdown In Orthopedic Growth
  186. Fastenal; Johnson & Johnson Net Falls
  187. 24-7StockAlert.net Announces Hot Stocks Alert Service On Market Movers
  188. J&J profits down, but top expectations; Study: ED drug users still see well;
  189. 24-7StockAlert.net Announces Hot Stocks Alert Service On Market Movers
  190. Stocks Move Lower on Weak Retail Sales
  191. Johnson & Johnson's 1Q In Line
  192. J&J Beats on Light Revenues
  193. Drug Stocks Retrench With Broader Market; J&J Gains
  194. 24-7StockAlert.net Announces Hot Stocks Alert Service On Market Movers
  195. Fears Of Economic Damage Ease For Replacement-Joint Makers
  196. Drug Stocks Retrench With Broader Market; J&J Gains
  197. 24-7StockAlert.net Announces Hot Stocks Alert Service On Market Movers
  198. Closing Bell: Set up profit taking on news (CVX, DNDN, FNM, GS, JNJ)
  199. Johnson & Johnson's 1Q In Line
  200. Johnson & Johnson’s profits stay healthy despite sales dip
  201. Income at J&T takes 2.5% hit
  202. USStocks Fall; Intel Net Drops 55%
  203. Global Investment News Briefs
  204. Solid results for J&J as generic competition batters key drugs
  205. Johnson and Johnson profits down 2.5%
  206. Johnson & Johnson Q1 net earnings decrease
  207. Global Investment News Briefs
  208. SurModics Remains a Sell
  209. J&J Changes Tack on Building Disease-Prevention Business
  210. J&J Changes Tack on Building Disease-Prevention Business
  211. Boston Scientific Announces First Quarter Special Items
  212. J&J Eliminates 900 Sales Positions
  213. Boston Scientific Announces First Quarter Special Items
  214. Boston Scientific Announces First Quarter Special Items
  215. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the
  216. J & J Slows Down With Economy, But Still Strong
  217. Johnson & Johnson to Webcast Annual Meeting of Shareholders
  218. Johnson & Johnson to Webcast Annual Meeting of Shareholders
  219. Johnson & Johnson to Webcast Annual Meeting of Shareholders
  220. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and
  221. Johnson and Johnson (JNJ) PriceWatch Alert Up To 13.12% Return
  222. J&J Turns to Pipeline as Generics Take Their Toll
  223. Earnings Preview: Boston Scientific
  224. Johnson and Johnson (JNJ) PriceWatch Alert for April 20, 2009
  225. Glaxo to Buy Stiefel Labs for $2.9 bln in Cash - Update
  226. Wachovia Upgrades Johnson & Johnson (JNJ) to Outperform; Entering Period of Accelerat
  227. Neutrogena launches Power Wave™ Cleanser in Hong Kong exclusively on YesStyle.com
  228. Neutrogena launches Power Wave™ Cleanser in Hong Kong exclusively on YesStyle.com
  229. Johnson and Johnson (JNJ) PriceWatch Alert for April 21, 2009
  230. Couponstar Business Soars Due to Worsening Economy Increasing Consumer Demand for Int
  231. Couponstar Business Soars Due to Worsening Economy Increasing Consumer Demand for Int
  232. iScience Raises $20.5 Million
  233. Johnson & Johnson opens its late-phase new chemical entity (NCE) facility in Mumbai
  234. iScience Raises $20.5 Million
  235. Johnson & Johnson opens its late-phase new chemical entity (NCE) facility in Mumbai
  236. J&J: Secrets of Success
  237. US STOCKS SNAPSHOT-Energy, pharma hit Dow; Nasdaq up
  238. J&J to Capitalize on Schering-Merck Deal
  239. Community First Bank Announces New Directors
  240. Designs Shine Even Brighter As LISTERINE(R) Whitening Helps Illuminate TVA's La Colle
  241. Baxter A Healthy Healthcare Holding (BAX, JNJ, BDX)
  242. Cosmetic Bootcamp Inaugurates Its First Skin of Color Symposium
  243. Cosmetic Bootcamp Inaugurates Its First Skin of Color Symposium
  244. Johnson & Johnson Announces Dividend Increase of 6.5%
  245. Wall Street down amid mixed earnings, downbeat economic data
  246. Pfizer Holders Want Say on Exec Pay; J&J Holders, Not So Much
  247. Health Stock Winners and Losers: JNJ Raises Dividend
  248. Wall Street down amid mixed earnings, downbeat economic data
  249. Wall Street down amid mixed earnings, downbeat economic data
  250. Wall Street down amid mixed earnings, downbeat economic data